Blog

  • Outbreak Reports: Identification of A Novel Human Adenovirus Type 114 Associated with An Acute Respiratory Disease Outbreak at An Elementary School — Beijing, China, September 2024



    On September 11, 2024, two classes at an elementary school in the Jingkai area reported multiple fever cases. Public health professionals from the local CDC immediately conducted an on-site epidemiological investigation. The school housed 189 classes with 7,368 students and 739 faculty and staff members. Overall sanitary conditions were satisfactory, and full-time school physicians were available onsite. All reported cases occurred exclusively among students; no teachers or staff members were affected. The two affected classes were situated on the east side of the same floor within the same building, positioned adjacent to the girls’ restroom where ventilation was observed to be inadequate.







    Epidemiological investigation revealed that the index case developed symptoms on September 9, including fever (reaching 38.6 °C), body aches, and nasal congestion. Between September 9 and 11, a total of 15 students from the 2 classes developed fever, with maximum recorded temperatures reaching 39.9 °C. Among these cases, 4 students experienced headache, fatigue, and other systemic symptoms; 3 reported cough and sore throat; 2 had muscle aches; 1 presented with nasal congestion; and 5 exhibited only fever. No hospitalizations, severe cases, or fatalities occurred. The temporal distribution of cases demonstrated a concentrated pattern: 5 cases on September 9, 6 cases on September 10, and 4 cases on September 11. Of the 15 affected individuals, 6 were male and 9 were female, with all students being 6 years old.







    A total of 14 throat swab samples were collected from the identified cases. Total viral nucleic acid was extracted using a nucleic acid extraction and purification kit (DA0623, Da’an, Guangzhou) with a nucleic acid extractor (Smart32, Da’an, Guangzhou). Comprehensive screening for respiratory pathogens was performed using a nucleic acid detection kit targeting 22 respiratory pathogens (Beijing Kangrun Gino) in combination with a PCR amplification instrument (TianLong Gentier 96R, Xi’an Tianlong). The screening panel included Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), influenza A (H1N1) pdm09 and A(H3N2), influenza B viruses, human respiratory syncytial virus, HAdV, human metapneumovirus, human rhinovirus, human parainfluenza virus (HPIV I-IV), human coronavirus (HCoV-NL63, -229E, -OC43, and -HKU1), human bocavirus, human enterovirus, Mycoplasma pneumoniae, Streptococcus pneumoniae, group A streptococcus, Bordetella pertussis, Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumoniae, Aspergillus, Chlamydia pneumoniae, Chlamydia psittaci, Cryptococcus, and Pneumocystis. HAdV-specific genes were detected in 10 of the 14 samples, while no other pathogens were identified, establishing HAdV as the causative agent of the outbreak.







    Six viral isolates were successfully obtained by inoculating the human epidermoid larynx carcinoma cell line (HEp-2 cells) with HAdV-positive samples. Cytopathic effects were monitored daily, and viral material was harvested when greater than 75% of the HEp-2 cells exhibited cytopathic changes. The six viral isolates were subsequently stored at −70 °C for further analysis.







    For preliminary genotyping, we amplified and sequenced the Loop2 region of the hexon gene from all six viral strains following national CDC protocols (3) (Table 1). For definitive genotyping, we amplified and sequenced the complete penton base gene (1,635 bp), hexon gene (2,935 bp), and fiber gene (960 bp) (4) (Table 1). All PCR products underwent bidirectional sequencing to ensure accuracy and reliability. We assembled and processed sequence data using Sequencher v5.0 software (Genecode,USA). Phylogenetic trees were constructed using both Neighbor-Joining and Maximum Likelihood (ML) methods in MEGA12, with bootstrap values set to 1,000 replicates for statistical validation. Reference sequences were obtained from the GenBank database.










    Table 1. 
    Primers used to amplify the target genome.




    Sequence analysis of the hexon Loop2 region revealed 100% identity among the six viral strains, all clustering with the HAdV-B3 genotype. Further analysis of the complete penton base gene, hexon gene, and fiber gene demonstrated 100% sequence identity among the six isolates. Phylogenetic analysis indicated that the penton base gene was closely related to HAdV-B7 (Figure 1), while the hexon gene and fiber gene were closely related to HAdV-B3 (Figure 1). According to the International Adenovirus Working Group guidelines for HAdV genotype identification (http://hadvwg.gmu.edu), this recombinant profile (P7H3F3) corresponds to the genotype HAdV-B114.









    Figure 1. 

    Phylogenetic tree of HAdV final genotyping based on the penton base gene, hexon gene, and fiber gene.

    Note: Representative HAdV strains isolated from one class; Representative HAdV strains isolated from another class; Prototype strains of representative types HAdV-B114; Prototype strains of representative types HAdV-B7; Prototype strains of representative types HAdV-B3.

    Abbreviation: HAdV=human adenovirus.





    Further analysis of amino acid sequence differences between the six HAdV-B114 strains revealed that the penton base demonstrated 99.2% amino acid homology with the HAdV-B7 reference strain, the hexon showed 99% amino acid homology with the HAdV-B3 reference strain, and the fiber exhibited 96.8% amino acid homology with the HAdV-B3 reference strain (Table 2). BLAST analysis further confirmed that the penton base gene, hexon gene, and fiber gene of the six HAdV strains exhibited the highest homology with the GenBank reference OR853835 for HAdV-B114 — at 99.9%, 100% and 99.8%, respectively. Therefore, the causative agent of this outbreak was conclusively identified as the novel recombinant HAdV type HAdV-B114.










    Table 2. 
    Variations in amino acids of human adenovirus type 114 (HAdV-114) strains.


    Continue Reading

  • Emerging Superbugs, Genomic Surveillance, and Innovative Countermeasures

    [1]

    Udaondo Z, Huertas MJ. Fighting the enemy: one health approach against microbial resistance. Microb Biotechnol 2020;13(4):888 − 91. https://doi.org/10.1111/1751-7915.13587.


    [2]

    GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet 2024;404(10459):1199 − 226. https://doi.org/10.1016/S0140-6736(24)01867-1.


    [3]

    Ma YY, Chen P, Mo Y, Xiao YH. WHO revised bacterial priority pathogens list to encourage global actions to combat AMR. hLife 2024;2(12):607 − 10. https://doi.org/10.1016/j.hlife.2024.10.003.


    [4]

    Painuli S, Semwal P, Sharma R, Akash S. Superbugs or multidrug resistant microbes: a new threat to the society. Health Sci Rep 2023;6(8):e1480. https://doi.org/10.1002/hsr2.1480.


    [5]

    Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E, et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis 2025;25(9):1033 − 43. https://doi.org/10.1016/S1473-3099(25)00118-5.


    [6]

    Ding L, Hu FP. China’s new national action plan to combat antimicrobial resistance (2022-25). J Antimicrob Chemother 2023;78(2):558 − 60. https://doi.org/10.1093/jac/dkac435.


    [7]

    Xiao YH, Nishijima T. Status and challenges of global antimicrobial resistance control: a dialogue between Professors Yonghong Xiao and Takeshi Nishijima. hLife 2024;2(2):47 − 9. https://doi.org/10.1016/j.hlife.2023.11.004.


    [8]

    Qin XH, Ding L, Hao M, Li P, Hu FP, Wang MG. Antimicrobial resistance of clinical bacterial isolates in China: current status and trends. JAC Antimicrob Resist 2024;6(2):dlae052. https://doi.org/10.1093/jacamr/dlae052.


    [9]

    Luo QX, Lu P, Chen YB, Shen P, Zheng BW, Ji JR, et al. ESKAPE in China: epidemiology and characteristics of antibiotic resistance. Emerg Microbes Infect 2024;13(1):2317915. https://doi.org/10.1080/22221751.2024.2317915.


    [10]

    Shen C, Luo L, Zhou HY, Xiao YL, Zeng JX, Zhang LL, et al. Emergence and ongoing outbreak of ST80 vancomycin-resistant Enterococcus faecium in Guangdong province, China from 2021 to 2023: a multicenter, time-series and genomic epidemiological study. Emerg Microbes Infect 2024;13(1):2361030. https://doi.org/10.1080/22221751.2024.2361030.


    [11]

    Chen HB, Yin YY, van Dorp L, Shaw LP, Gao H, Acman M, et al. Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China. Genome Med 2021;13(1):171. https://doi.org/10.1186/s13073-021-00992-x.


    [12]

    Zhou WX, Jin Y, Chen P, Ge Q, Dong X, Chen YB, et al. Reshaping the battlefield: a decade of clonal wars among Staphylococcus aureus in China. Drug Resist Updat 2025;78:101178. https://doi.org/10.1016/j.drup.2024.101178.


    [13]

    Li P, Liang QQ, Liu WG, Zheng BW, Liu LZ, Wang W, et al. Convergence of carbapenem resistance and hypervirulence in a highly-transmissible ST11 clone of K. pneumoniae: an epidemiological, genomic and functional study. Virulence 2021;12(1):377 − 88. https://doi.org/10.1080/21505594.2020.1867468.


    [14]

    Chen T, Ying LY, Xiong LY, Wang XT, Lu P, Wang Y, et al. Understanding carbapenem-resistant hypervirulent Klebsiella pneumoniae: key virulence factors and evolutionary convergence. hLife 2024;2(12):611 − 24. https://doi.org/10.1016/j.hlife.2024.06.005.


    [15]

    Shi JC, Mao XT, Sun FT, Cheng JH, Shao LY, Shan X, et al. Epidemiological characteristics and antimicrobial resistance of extensively drug-resistant Acinetobacter baumannii in ICU wards. Microbiol Spectr 2025;13(4):e02619 − 24. https://doi.org/10.1128/spectrum.02619-24.


    [16]

    Song YQ, Mu YQ, Wong NK, Yue Z, Li J, Yuan M, et al. Emergence of hypervirulent Pseudomonas aeruginosa pathotypically armed with co-expressed T3SS effectors ExoS and ExoU. hLife 2023;1(1):44 − 56. https://doi.org/10.1016/j.hlife.2023.02.001.


    [17]

    Wheeler NE, Price V, Cunningham-Oakes E, Tsang KK, Nunn JG, Midega JT, et al. Innovations in genomic antimicrobial resistance surveillance. Lancet Microbe 2023;4(12):e1063 − 70. https://doi.org/10.1016/S2666-5247(23)00285-9.


    [18]

    Weinmaier T, Conzemius R, Bergman Y, Lewis S, Jacobs EB, Tamma PD, et al. Validation and application of long-read whole-genome sequencing for antimicrobial resistance gene detection and antimicrobial susceptibility testing. Antimicrob Agents Chemother 2023;67(1):e01072 − 22. https://doi.org/10.1128/aac.01072-22.


    [19]

    Wang Q, Wang RB, Wang SY, Zhang AR, Duan QY, Sun SJ, et al. Expansion and transmission dynamics of high risk carbapenem-resistant Klebsiella pneumoniae subclones in China: an epidemiological, spatial, genomic analysis. Drug Resist Updat 2024;74:101083. https://doi.org/10.1016/j.drup.2024.101083.


    [20]

    Wu YL, Chu WW, Hu XQ, Lyu YY, Tai JH, Li RJ, et al. Genomic characteristics and phylogenetic analyses of colonization and infection with carbapenem-resistant Klebsiella pneumoniae in multicenter intensive care units: a cohort study. Microbiol Spectr 2025;13(4):e01584 − 24. https://doi.org/10.1128/spectrum.01584-24.


    [21]

    Cipriani G, Helmersen K, Mazzon RR, Wagner G, Aamot HV, Ferreira FA. Evaluation of whole-genome sequencing protocols for detection of antimicrobial resistance, virulence factors and mobile genetic elements in antimicrobial-resistant bacteria. J Med Microbiol 2025;74(3):001990. https://doi.org/10.1099/jmm.0.001990.


    [22]

    Chen QW, Liu LZ, Hu XF, Jia X, Gong XW, Feng YJ, et al. A small KPC-2-producing plasmid in Klebsiella pneumoniae: implications for diversified vehicles of carbapenem resistance. Microbiol Spectr 2022;10(3):e02688 − 21. https://doi.org/10.1128/spectrum.02688-21.


    [23]

    Liu LZ, Lou NJ, Liang QQ, Xiao W, Teng GQ, Ma JG, et al. Chasing the landscape for intrahospital transmission and evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae. Sci Bull (Beijing) 2023;68(23):3027 − 47. https://doi.org/10.1016/j.scib.2023.10.038.


    [24]

    Huang M, Liu LZ, Li XX, Shi Y, Zhang HM, Lu T, et al. Heterogeneity and clinical genomics of blaKPC-2-producing, carbapenem-resistant Pseudomonas aeruginosa. hLife 2024;2(6):314 − 9. https://doi.org/10.1016/j.hlife.2024.04.001.


    [25]

    Sun SW, Chen XYZ. Mechanism-guided strategies for combating antibiotic resistance. World J Microbiol Biotechnol 2024;40(10):295. https://doi.org/10.1007/s11274-024-04106-8.


    [26]

    Feng J, Zheng YL, Ma WQ, Ihsan A, Hao HH, Cheng GY, et al. Multitarget antibacterial drugs: an effective strategy to combat bacterial resistance. Pharmacol Ther 2023;252:108550. https://doi.org/10.1016/j.pharmthera.2023.108550.


    [27]

    Li ZW, Guo ZH, Lu X, Ma XC, Wang XK, Zhang R, et al. Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs. Acta Pharm Sin B 2023;13(7):3067 − 79. https://doi.org/10.1016/j.apsb.2023.03.002.


    [28]

    Jia J, Zheng MX, Zhang CW, Li BL, Lu C, Bai YF, et al. Killing of Staphylococcus aureus persisters by a multitarget natural product chrysomycin A. Sci Adv 2023;9(31):eadg5995. https://doi.org/10.1126/sciadv.adg5995.


    [29]

    Liu JY, Cao YG, Xu CG, Li RC, Xiong YY, Wei Y, et al. Quaternized antimicrobial peptide mimics based on harmane as potent anti-MRSA agents by multi-target mechanism covering cell wall, cell membrane and intracellular targets. Eur J Med Chem 2024;276:116657. https://doi.org/10.1016/j.ejmech.2024.116657.


    [30]

    Liu F, Dawadi S, Maize KM, Dai R, Park SW, Schnappinger D, et al. Structure-based optimization of pyridoxal 5’-phosphate-dependent transaminase enzyme (BioA) inhibitors that target biotin biosynthesis in Mycobacterium tuberculosis. J Med Chem 2017;60(13):5507 − 20. https://doi.org/10.1021/acs.jmedchem.7b00189.


    [31]

    Xu YC, Yang J, Li WH, Song SJ, Shi Y, Wu LH, et al. Three enigmatic BioH isoenzymes are programmed in the early stage of mycobacterial biotin synthesis, an attractive anti-TB drug target. PLoS Pathog 2022;18(7):e1010615. https://doi.org/10.1371/journal.ppat.1010615.


    [32]

    Shi Y, Cao QD, Sun J, Hu XF, Su Z, Xu YC, et al. The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity. PLoS Pathog 2023;19(1):e1011110. https://doi.org/10.1371/journal.ppat.1011110.


    [33]

    Huang HM, Chang SH, Cui T, Huang M, Qu JX, Zhang HM, et al. An inhibitory mechanism of AasS, an exogenous fatty acid scavenger: implications for re-sensitization of FAS II antimicrobials. PLoS Pathog 2024;20(7):e1012376. https://doi.org/10.1371/journal.ppat.1012376.


    [34]

    Su Z, Zhang WZ, Shi Y, Cui T, Xu YC, Yang RS, et al. A bacterial methyltransferase that initiates biotin synthesis, an attractive anti-ESKAPE druggable pathway. Sci Adv 2024;10(51):eadp3954. https://doi.org/10.1126/sciadv.adp3954.


    [35]

    MacNair CR, Rutherford ST, Tan MW. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat Rev Microbiol 2024;22(5):262 − 75. https://doi.org/10.1038/s41579-023-00993-0.


    [36]

    Xu T, Yan XT, Kang AY, Yang LH, Li XH, Tian Y, et al. Development of membrane-targeting fluorescent 2-phenyl-1H-phenanthro[9,10-d]imidazole-antimicrobial peptide mimic conjugates against methicillin-resistant Staphylococcus aureus. J Med Chem 2024;67(11):9302 − 17. https://doi.org/10.1021/acs.jmedchem.4c00436.


    [37]

    Sousa CA, Ribeiro M, Vale F, Simões M. Phenazines: natural products for microbial growth control. hLife 2024;2(3):100 − 12. https://doi.org/10.1016/j.hlife.2023.11.005.


    [38]

    Rafiq MS, Shabbir MA, Raza A, Irshad S, Asghar A, Maan MK, et al. CRISPR-Cas system: a new dawn to combat antibiotic resistance. BioDrugs 2024;38(3):387 − 404. https://doi.org/10.1007/s40259-024-00656-3.


    [39]

    Li Y, Cui XY, Yang XY, Liu GQ, Zhang J. Artificial intelligence in predicting pathogenic microorganisms’ antimicrobial resistance: challenges, progress, and prospects. Front Cell Infect Microbiol 2024;14:1482186. https://doi.org/10.3389/fcimb.2024.1482186.


    [40]

    Beyer P, Paulin S. The antibacterial research and development pipeline needs urgent solutions. ACS Infect Dis 2020;6(6):1289 − 91. https://doi.org/10.1021/acsinfecdis.0c00044.


    [41]

    Gao GF, Hoffmann JA, Walzer C, Lu JH. Global public health crisis response: a roundtable discussion with Professor George Fu Gao, Professor Jules A Hoffmann, Professor Chris Walzer and Professor Jiahai Lu. hLife 2023;1(2):63 − 70. https://doi.org/10.1016/j.hlife.2023.10.001.


    Continue Reading

  • Diabetes cases nearly double in children and teens worldwide

    Diabetes cases nearly double in children and teens worldwide

    New global data show a dramatic surge in childhood and adolescent diabetes, especially type 2, yet improved care is helping reduce mortality worldwide. 

    Study: Analysis of the global burden of diabetes and attributable risk factor in children and adolescents across 204 countries and regions from 1990 to 2021. Image credit: mother_ana/Shutterstock.com

    A recent study in Frontiers in Endocrinology examined trends in diabetes among children and adolescents in 204 countries and regions. The incidence of diabetes has sharply increased in children and adolescents, but diabetes-related mortality has declined over time.

    The growing threat of diabetes

    Diabetes is a severe chronic condition typically resulting from insulin deficiency. As of 2019, it affected 460 million people worldwide and was the eighth leading cause of death and disability. Forecasts indicate that the number of individuals with diabetes may increase to an alarming 783 million by 2045. This shows the substantial burden that diabetes can impose on the healthcare system.

    Diabetes is predominantly classified as type 1 (T1D) and type 2 diabetes (T2D). Recent evidence points to a rising incidence of diabetes among younger individuals. Despite the progress made in prevention strategies, they have not been able to prevent the trend of early onset of diabetes and the rising incidence. To aid in better disease management in the younger population, it is crucial to understand the global epidemiological trends of diabetes in children and adolescents (age less than 20 years).

    About the study

    This study extracted data from the Global Burden of Disease (GBD) database for 204 countries and regions from 1990 to 2021 to examine trends in diabetes among children and adolescents. It also considers diabetes-related mortality and examines the associated risk factors. The GBD 2021 provides extensive mortality, incidence, and Disability-Adjusted Life Years (DALYs) data.

    The Socio-Demographic Index (SDI) is a composite metric of a country’s developmental status and is significantly associated with health outcomes. Using its values between 0 (least developed) and 1 (most developed), the countries were categorized into low SDI, low-middle SDI, middle SDI, high-middle SDI, and high SDI regions. The patients were also divided into subgroups by age, namely, 15-19 years, 10 – 14 years, 5 – 9 years, 2 – 4 years, and under 1 year.

    Sixty-six specific attributable risk factors were identified, including lead exposure, high consumption of red meat, particulate pollution, extreme temperatures, active and passive smoking, high sodium intake, and others. However, data were available only on three risk factors: elevated fasting blood glucose and high and low temperatures.

    Study findings

    Globally, diabetes incidence among children and adolescents has increased by approximately 94% from 25.77 per 100,000 in 1990 to 49.99 per 100,000 in 2021. The incidence of T2D has surpassed that of T1D, and T2D now contributes more to the rising disease burden; despite this, T1D still accounts for a higher mortality rate. Before 2020, the incidence rates were higher in females than in males. Across all five SDI categories, rates increased, with the lowest burden in low SDI regions and the highest in high-middle SDI regions.

    Concerning geographical regions, the highest incidence rates were seen in Oceania. The most notable increases were in East Asian Regions, North Africa, and the Middle East. India and China report the highest numbers of diabetes cases at the national level. Pakistan also showed a significant increase in cases between 1990 and 2021.

    The diabetes-related death rate among children and adolescents declined from 0.39 per 100,000 in 1990 to 0.31 per 100,000 in 2021. T1D-related deaths were significantly higher than T2D, and the death rates were comparable between males and females. However, whilst T1D mortality declined, the T2D mortality rate rose slightly from 0.06 to 0.08 per 100,000.

    High SDI regions recorded the lowest death rates at the SDI level, while low SDI regions carried the highest. Oceania had the highest regional death rate overall, whereas East Asia saw a significant decline. India reported the highest number of deaths, while China showed a marked decrease during the study period.

    The overall DALY rate among children and adolescents declined during the study period, from 39.45 per 100,000 in 1990 to 37.83 per 100,000 in 2021. The DALY rate for T2D increased, while that for T1D decreased. Despite this, T1D DALY rates remain higher overall than those of T2D.

    The reduction significantly influenced the overall decline in the diabetes DALY rate for females. For males, the DALY rate remained stable. An increase in the diabetes DALY rate was noted only in the high SDI region. In contrast, the low SDI region showed the most pronounced decline in DALY rates. Oceania showed the highest DALY rate, while India not only exhibited the highest total diabetes DALYs but also an increasing trend. Conversely, China’s total diabetes DALYs decreased between 1990 and 2021.

    The highest diabetes incidence was noted in the 15–19-year-old age group, both across the five SDI regions and globally. In some subgroup analyses, however, the 10-14-year-old age group also showed particularly high incidence rates. For patients under 1 year of age, the mortality and DALY rates for T1D were significantly higher than those of other age groups.

    Among the risk factors, the main determinant of diabetes-related mortality and DALYs in children and adolescents is elevated fasting blood glucose. The study also projected, using ARIMA models, that the global incidence of diabetes in children and adolescents will continue to rise over the next 15 years, while mortality is expected to keep declining.

    Conclusions

    The results show that diabetes-related mortality in children and adolescents has declined over time. However, the marked increase in incidence is alarming and seriously threatens global child and adolescent health.

    A key limitation of the current study is data quality, as several countries may have a significantly high number of undiagnosed diabetes cases and may also lack data on risk factors. Furthermore, epidemiological methods could not be used to study the data because the data provided by GBD are aggregate.

    Download your PDF copy now!

    Continue Reading

  • Unfiltered series 4 confirmed by BBC Scotland promising more hustle and more glamour

    Unfiltered series 4 confirmed by BBC Scotland promising more hustle and more glamour

    The Agency girls are back! BBC Scotland has commissioned a fourth series of the BAFTA Scotland-winning reality show The Agency: Unfiltered – the hit series that takes viewers beyond the Instagram posts to reveal the real, unfiltered world of social media influencers.

    Produced by IWC Media (a Banijay UK company), the show lifts the lid on life inside Aquarius Creative, Scotland’s largest influencer agency. Based in Hamilton and run by businesswomen Kirsten Cameron and Amy Moore, the agency represents some of the UK’s most in-demand influencers.

    Audiences will once again get an inside look at the highs and lows of running an influencer marketing agency, alongside the personal lives of Kirsten, Amy, their team, and the influencers they represent.

    Series 3 was a smash hit with younger audiences, thanks to the hugely popular TikTok Academy, where six rising TikTok stars competed to be represented by Aquarius, generating plenty of buzz on social media with all its twists and turns. Series 4 promises to raise the stakes even higher. With the agency expanding its reach, Kirsten and Amy now have their sights set on signing fresh talent from across the UK with the return of the TikTok Academy. Expect more hustle, more glamour, and even more drama!

    The fourth series of The Agency: Unfiltered is set to launch on BBC Scotland and BBC iPlayer in 2026. For those who missed the drama, all episodes of Series 3 are available to stream now on BBC iPlayer.

    Steve Allen, Commissioning Executive at BBC Scotland, said: “We’re thrilled to be bringing The Agency: Unfiltered back for a fourth series! The show has been a huge hit with younger viewers who love this unique, behind-the-scenes look at the world of influencing. It’s a busy world and we’re excited to see what the fourth series brings in terms of new stories and characters.”

    Laura Capaldi, Executive Producer at IWC, said: “We’re so excited that The Agency: Unfiltered is returning for its fourth series. This series will see the Aquarius Academy back with a bang and the up-and-coming TikTokers will be going to extreme lengths to get that coveted contract with Aquarius. Watch this space!”

    Kirsten and Amy, the founders of Aquarius Creative, are equally excited about the new series: “We’re absolutely buzzing to be back for a fourth series! Having the cameras follow us has become so normal, and we’re excited to let viewers back into our lives to experience all the madness that comes with the world of influencing – there’s never a dull day at Aquarius! We’re growing the business even further, and we’re thrilled to bring audiences along for the ride. Strap in!”

    The Agency: Unfiltered is an IWC Media production for BBC Scotland. Banijay Rights handles international distribution for The Agency. Executive producers for IWC Media are Laura Capaldi and Mark Downie. The series was commissioned by Steve Allen, commissioning executive for BBC Scotland.

    RS

    Follow for more

    Continue Reading

  • Living in polluted areas increases heart failure risk by 27%, BHF study finds

    Living in polluted areas increases heart failure risk by 27%, BHF study finds

    credit: yevtony/ istock

    New research from the British Heart Foundation reveals that residing in the most polluted UK areas raises heart failure risk by 27%

    A recent study by the British Heart Foundation has uncovered a concerning link between air pollution and heart health. Individuals living in the top 10% of UK areas with the highest PM2.5 pollution levels face a 27% increased risk of developing heart failure compared to those in the least polluted regions. This significant finding underscores the urgent need for improved air quality to protect cardiovascular health nationwide.

    27% increased risk of heart failure following PM2.5 exposure

    PM2.5 is a pollutant released from various sources, such as traffic emissions and industrial processes. These particles are 30 times smaller than the width of a human hair, meaning they are small enough to get into the bloodstream after being inhaled.

    To understand the impact of PM2.5 on health, researchers analysed data from the UK Biobank health study, which included 299,323 people. Following this, they investigated rates of strokes and heart failure in the same cohort over a decade.

    Individuals living in the worst 10% of areas for PM2.5 pollution had a 27% higher risk of developing heart failure compared to those living in the best 10% of areas for PM2.5 pollution. The risk of having a stroke was 7% higher for those in the worst places.

    Living in polluted areas ages your heart

    Based on figures from 2010, the most polluted areas in the UK pumped out 3.7 micrograms of PM2.5 per cubic metre of air, compared to the least polluted areas in an average year. 

    For every extra one microgram of PM2.5, the risk of developing heart failure increased by 7% and the risk of stroke by 3%.

    Additionally, people exposed to higher levels of PM2.5 were more likely to have a smaller left ventricle, the main pumping chamber of the heart. The researchers suggest this is typical of an ‘older heart’. 

    Ghita Housni, PhD student at the William Harvey Research Institute, within Queen Mary University of London, said: 

    “We know cleaner air means healthier hearts, and this research lays bare the impact of air pollution on public health. Reducing your exposure to air pollution is a crucial part of preventing heart conditions in the modern age and lowering your risk of heart failure and stroke.  We need to improve air quality by introducing public health strategies which strongly prioritise cardiovascular protection.” 

    Environmental health is a growing issue

    When PM2.5 is inhaled, the immune system triggers inflammation. When the blood vessels become inflamed, they become stiffer and more prone to fatty build-up. This causes high blood pressure, which increases the risk of a stroke. The heart will also work harder to pump blood through inflamed blood vessels, which can lead to heart failure.

    After taking into account factors that affect stroke risk, such as age and smoking, researchers found that only a small proportion of people in the study had a stroke. It is estimated that only one extra person in every 100 experiences a stroke in the top 10% of polluted areas, compared to areas with the least pollution. Only an additional two people in every 100 developed heart failure. 

    Dr Sonya Babu-Narayan, Clinical Director at the British Heart Foundation, said:  

    “We know there are no safe levels of air pollution. These early findings, linking high PM2.5 levels to heart failure, add to a growing body of evidence that poor air quality is detrimental to our hearts. 

    “It’s good to know that the kind of PM2.5 levels experienced by the people in this study have already improved since the introduction of Government targets in 2021. Nevertheless, these levels still exceed World Health Organisation guidelines. Going further to reduce air pollution could help the UK to prevent premature cardiovascular disease, and save and improve lives for current and future generations.”

    Continue Reading

  • Ardagh Group publishes 2024 Sustainability Report

    Ardagh Group publishes 2024 Sustainability Report

    LUXEMBOURG, Sept. 12, 2025 /PRNewswire/ — Ardagh Group, a global leader in sustainable aluminium and glass packaging, today announced the publication of its 2024 Sustainability Report. The 2024 Sustainability Report includes information on Ardagh Group’s two operating businesses – Ardagh Metal Packaging (AMP) and Ardagh Glass Packaging (AGP). The report underscores Ardagh Group’s ongoing commitment to transparency, accountability and driving positive environmental and social change. In a year marked by both growth and challenges, Ardagh Group continued to advance its sustainability agenda, guided by the strategic pillars of Emissions, Ecology and Social.

    Although the European Union’s Corporate Sustainability Reporting Directive (CSRD) and the related European Sustainability Reporting Standards (ESRS) are not currently in force with respect to Ardagh Group, we have nevertheless developed the 2024 Sustainability Report with the goal of integrating the current CSRD and ESRS structure, to the extent practicable, reflecting Ardagh Group’s dedication to enhanced ESG disclosure and responsible business practices.

    Key highlights include:

    • Renewable Electricity: AMP increased global renewable electricity coverage to 30%, with strong regional progress (Europe: 46%, South America: 43%), with AGP boosting its renewable electricity coverage to 22% (Europe: 48%)
    • GHG Emissions:
      • Scope 1 & 2: AMP achieved 10% emissions reduction versus 2023; 18% emissions intensity reduction versus the 2020 baseline, while AGP achieved a 12% reduction versus 2023, 16% lower than 2020 levels.
      • Scope 3: AMP achieved a 25% reduction versus the 2020 baseline, surpassing the 2030 target, while AGP achieved 10% reduction versus the 2020 baseline.
    • Circularity: AMP’s beverage cans are made with an average recycled content of 78% recycled aluminium, among the highest in the industry, based on peer disclosures. 56% of the glass used in AGP’s production processes was recycled cullet (internal and external).
    • Waste and Water: 83% of AMP’s facilities achieved Zero Waste to Landfill (ZWTL), while AGP increased its ZWTL rate to 35%. AMP’s water withdrawal intensity improved 5% over the previous year. AGP’s water withdrawal intensity improved 13% over the same period.

    Social and Governance Progress:

    • The Group’s flagship programme, Ardagh for Education, invested $13 million across 44 communities, benefiting over 210,000 students with hands-on STEM learning opportunities in approximately 680 schools.
    • Ardagh Group was recognised with an EcoVadis Gold Medal for sustainability management and listed on the CDP A List for supplier engagement,
    • In addition, Merck Life Science named AGP as an ‘Outstanding Partner’.

    “Our 2024 Sustainability Report provides detailed insights into our environmental, social and governance performance.” said Herman Troskie, Chair, Ardagh Group. “We continued to make meaningful progress toward our sustainability goals, guided by our Core Values of Inclusion, Trust, Teamwork and Excellence. As a leading manufacturer of highly recyclable aluminium and glass packaging, we understand the responsibility we carry – and the opportunity we have – to contribute to a more sustainable future for both the planet and the communities we serve. While our beverage can business delivered strong growth, our glass division navigated a more challenging and dynamic trading environment. Through it all, we remained focused and disciplined, and we continued to invest for a more sustainable future across the Group.”

    The report also serves as a supplement to Ardagh Group’s 2025 Communication on Progress (COP) to the UN Global Compact and reinforces Ardagh’s long-term ESG roadmap.

    To access the full 2024 Sustainability Report, please visit the Ardagh Group Sustainability Report. To access the stand-alone AMP 2024 sustainability report, please visit the Ardagh Metal Packaging (AMP) Report.

    Notes to the editor 

    Ardagh Group is a global supplier of sustainable, inherently recyclable, metal and glass packaging for brand owners around the world. Ardagh operates 58 metal and glass production facilities in 16 countries, employing approximately 19,000 people with sales of $9.1bn in 2024

    SOURCE Ardagh Group S.A.

    Continue Reading

  • Swiped to Twiggy: the seven best films to watch on TV this week | Television

    Swiped to Twiggy: the seven best films to watch on TV this week | Television

    Pick of the week
    Swiped

    As she’s still bound by an NDA, Whitney Wolfe Herd did not contribute to her own biopic. But even this fictionalised account of the career of the co-founder of dating app Tinder and creator of Bumble paints a damning picture of the toxic, misogynistic culture that permeates Silicon Valley. In Rachel Lee Goldenberg’s sadly still timely film, Lily James stars as Whitney, a peppy college graduate lucking her way into a startup incubator run by Sean Rad (Ben Schnetzer). It portrays the subsequent diminishing of her key role in the success of Tinder, which runs parallel with the collapse of her relationship with colleague Justin (Jackson White), amid gaslighting, trolling and sexual harassment.
    Friday 19 September, Disney+


    Hue and Cry

    Harry Fowler (centre) in Hue and Cry. Photograph: Ronald Grant Archive

    This early Ealing comedy must have been ideal fodder for the Saturday matinee slot in late-40s cinemas, featuring all the thrills, spills and intrigue a youngster could want. Harry Fowler plays Joe, the leader of a gang of boys (and one girl) who hang out in the bombed-out houses of postwar London. When he discovers that the plot of a story in his favourite magazine, Trump, mirrors real-life criminal events, he and his mates investigate. Alastair Sim has a nifty cameo as the writer whose work is being manipulated (“here’s a split infinitive!”) but it’s down to the kids to save the day.
    Saturday 13 September, 11am, Film4


    Tár

    Bravura … Cate Blanchett in Tár.
    Photograph: Pictorial Press Ltd/Alamy

    It has caused some disquiet by having its lead character, a woman, suspected of grooming, but Todd Field’s bravura drama is a fascinating and often unnerving exploration of the peaks and pitfalls of high-end creativity. Cate Blanchett plays Lydia Tár, the chief conductor of the Berlin Philharmonic, a celebrated figure in love with her own voice. She’s married to first violin Sharon (Nina Hoss), with whom she has an adopted daughter. But her bullish self-confidence doesn’t help her cause when dark revelations about a past relationship surface.
    Sunday 14 September, 10pm, BBC Two


    Twiggy

    Tremendous company … Twiggy. Photograph: BBC/Soho Talent/Alamy/Pictorial Press

    She was too short, too thin and didn’t have a bust. But in 1966, model Lesley Hornby, AKA Twiggy, rapidly became the face of the swinging decade – her cropped hair, wide eyes and gamine style sought after by fashion magazines and young women in the UK and abroad. Sadie Frost’s laudatory documentary reveals how a smiley, 16-year-old, working-class Londoner survived instant fame, then carved out a successful career in movies, theatre, TV and music. And Twiggy herself is tremendous company, remarkably grounded despite her whirlwind of a life.
    Monday 15 September, 9pm, BBC Two

    skip past newsletter promotion


    Bob & Carol & Ted & Alice

    Four in a bed … Elliott Gould, Natalie Wood, Robert Culp and Dyan Cannon in Bob & Carol & Ted & Alice. Photograph: Columbia Pictures/Allstar

    What happens when the era of free love arrives and you’re already middle-aged and married? In Paul Mazursky’s witty, gimlet-eyed 1969 drama, that’s the tangle documentary film-maker Bob (Robert Culp) and his wife Carol (Natalie Wood) find themselves in after a wellness retreat gets them hooked on emotional honesty. Awkwardly, their best friends Ted and Alice (Elliott Gould and Dyan Cannon) are less keen on their disruptive modern ways.
    Monday 15 September, 9.05pm, Talking Pictures TV


    Bram Stoker’s Dracula

    Gloriously maximalist … Winona Ryder and Gary Oldman in Bram Stoker’s Dracula. Photograph: Ronald Grant Archive

    In his 1992 gothic horror, Francis Ford Coppola takes a gloriously maximalist approach to the vampire yarn, stuffing it with nods to film styles of the past. He also prioritises the romance between Gary Oldman’s undead old count and ingenue Mina (Winona Ryder) over visceral shocks, while there is a pointed contrast made between the Victorian love of technology and the repressed but unstoppable desires of the flesh. These pulls between ancient and modern even find an inadvertent echo in the very 90s Keanu Reeves and his struggles with an English accent as fall-guy solicitor Harker.
    Monday 15 September, 11.30pm, BBC Two


    Good Luck to You, Leo Grande

    Prioritise pleasure … Emma Thompson and Daryl McCormack in Good Luck to You, Leo Grande. Photograph: AP

    Soon-to-be national treasure Emma Thompson gives a wonderfully candid performance in Sophie Hyde’s poignant drama about a late-in-life sexual awakening. Her widowed, retired teacher Nancy hires “aesthetically perfect” sex worker Leo (Daryl McCormack) for an afternoon in a hotel room in the hope of discovering a physical pleasure she never knew during her long marriage. There’s much more talking than sex, but the two leads perfectly balance the awkwardness, humour, tension and emotional mic drops that characterise their transactional encounters.
    Wednesday 17 September, 9pm, Film4

    Continue Reading

  • Security delivered for working people as UK-US ties strengthened with new Google Cloud partnership for classified information sharing – GOV.UK

    Security delivered for working people as UK-US ties strengthened with new Google Cloud partnership for classified information sharing – GOV.UK

    1. Security delivered for working people as UK-US ties strengthened with new Google Cloud partnership for classified information sharing  GOV.UK
    2. Google Cloud Awarded Landmark Sovereign Cloud Contract with UK Ministry of Defence  Google Cloud Press Corner
    3. UK announces £400m Google Cloud classified info contract  Macau Business

    Continue Reading

  • NDMA Warns of More Rainfall and Flood

    NDMA Warns of More Rainfall and Flood

    National Disaster Management Authority (NDMA) Chairman Inam Haider Malik said on Thursday that the ongoing monsoon spell will continue for another two to three days, according to a weather update reported by 24NewsHD TV.

    Flood Situation and Relief Efforts

    Malik stated that water levels remained high at Head Panjnad and Guddu Barrage, leading to widespread flooding that destroyed crops and swept away livestock in several regions. However, he noted that the flood situation in the Sutlej, Ravi, and Chenab rivers was now under control.

    Rescue operations are ongoing, with 2.4 million people evacuated to safer locations in Punjab and 1.5 million relocated in Sindh. Malik thanked welfare organizations for their support and highlighted that all government institutions were working together to strengthen future disaster preparedness.

    Relief Distribution

    The NDMA chairman said that embankments were breached in some areas to reduce pressure on rivers. He confirmed that the Punjab government provided 9,000 tents and ration bags, while over 9,000 tons of food supplies were distributed among flood-affected communities in the province.

    Forecast and Climate Challenges

    Looking ahead, Malik warned of further rainfall in central Punjab and Azad Kashmir between September 16 and 18. He also stressed the urgent need for collective action against climate change, noting that rapid glacier melt caused by rising temperatures was intensifying flood risks.


    Continue Reading

  • Nepal's former chief justice Karki likely to be interim PM, source says – Reuters

    1. Nepal’s former chief justice Karki likely to be interim PM, source says  Reuters
    2. Nepal seeks new leader as army reclaims streets after protest violence  Dawn
    3. Nepal army says in talks with protesters to decide on interim leader  Al Jazeera
    4. “Non-Controversial, well respected figure in Nepalese society”: Ex-Diplomat after Gen Z protestors back Sushila Karki as Interim PM  ANI News
    5. Nepal: When Sushila Karki’s husband hijacked plane carrying Indian actor Mala Sinha  Firstpost

    Continue Reading